GeneDx 的收益和收入超出预期，首席执行官和首席财务官出售了 $11.3M 的股票。 GeneDx beats earnings and revenue forecasts, with CEO and CFO selling $11.3M in shares.

基因组学服务提供商 GeneDx 报告称，季度收益强劲，为每股 0.70 美元，远高于预期的 0.04 美元，收入为 9564 万美元，高于预期的 8224 万美元。 GeneDx, a genomics service provider, reported strong quarterly earnings of $0.70 per share, significantly above estimates of $0.04, with revenue at $95.64 million, surpassing forecasts of $82.24 million. 该公司的股票开盘价为 111.31 美元，市值为 30.6 亿美元。 The company's stock opened at $111.31, with a market cap of $3.06 billion. GeneDx 的首席执行官兼首席财务官最近出售了股票，在 90 天内总计 1130 万美元的内幕销售。 GeneDx's CEO and CFO recently sold shares, totaling $11.3 million in insider sales over 90 days. 分析师给予该股“适度买入”评级，目标价为 72.33 美元。 Analysts have given the stock a "Moderate Buy" rating with a price target of $72.33.